1. 12 Aspects GMP

Embed Size (px)

Citation preview

  • 8/3/2019 1. 12 Aspects GMP

    1/59

    GOOD MANUFACTURING PRACTICE

    ASPECTS OF GMP

    PUTRI HASANAH RAHMIN

    0811012051

    FACULTY OF PHARMACY

    ANDALAS UNIVERSITY

  • 8/3/2019 1. 12 Aspects GMP

    2/59

    GMPs are part of the qualityassurance activities that ensure thatproducts are consistently produced

    and controlled to the qualitystandards appropriate to theirintended use and required by the

    drug regulatory authorities.

  • 8/3/2019 1. 12 Aspects GMP

    3/59

    Aspects of GMP

    GMP guidelines in

    accordance with the POMcovers 12 aspects:

    1. quality management

    2. personnel

    3. premises and facilities

    4. equipment

    5. sanitation and hygiene

    6. production

    7) quality control

    8) self-inspections andquality audits

    9) handling of productcomplaints and productrecalls and productreturns,

    10) documentation

    11) making and analysisbased on contract

    12) qualification andvalidation

  • 8/3/2019 1. 12 Aspects GMP

    4/59

    1. QUALITY MANAGEMENT

    The pharmaceutical industry must be able to make

    drugs to suit the intended use, meets therequirements specified in the authorizationdocument and does not pose risks that endangerusers. There is a need for quality management to

    achieve consistent quality thoroughly designed andimplemented correctly.

    Basic elements of quality management are: Anappropriate quality system includes organizational

    structure, procedures, processes and resources.

  • 8/3/2019 1. 12 Aspects GMP

    5/59

    Continue

    Systematic actions necessary toobtain assurance with a high levelof confidence, so that products (orservices) generated always meet

    predefined requirements. Theentire action is called the Qualityassurance.

  • 8/3/2019 1. 12 Aspects GMP

    6/59

    Continue

    In the aspect of quality management areimportant matters, namely:

    Quality assurance (QA)

    Quality assurance is the totality of all

    measurements are made with a view to ensuringthat the drug is produced with quality inaccordance with the purpose of use.

  • 8/3/2019 1. 12 Aspects GMP

    7/59

    Continue

    GoodManufacturing Practice (GMP)

    Part of quality assurance which ensures that thedrug created and consistently to achieve thedesired quality standards appropriate to the

    intended use and as required in the marketingauthorization and product specifications. GMPcovers all production and quality control.

  • 8/3/2019 1. 12 Aspects GMP

    8/59

    Continue Quality control (QC)

    Part of the GMP are associated withsampling, specifications and the necessaryand relevant tests have been performed andthe materials that have not been released isnot used as well as products not yet releasedcan not be sold or supplied before theirquality assessed and found to qualify.Function / agency should be independent ofother parts.

  • 8/3/2019 1. 12 Aspects GMP

    9/59

    Assessment of product quality

    Assessment of quality of productsmade periodically to all registered drug,including export products to prove theconsistency of the process, the suitability ofthe specifications for starting materials,packaging materials and finished drug, to see

    trends and identify where improvement isusually done every year and documented,taking into account previous review .

  • 8/3/2019 1. 12 Aspects GMP

    10/59

    2. PERSONNEL

    The number of employees in all parts should havesufficient knowledge, skills and abilities in

    accordance with their fields, have mental andphysical health is good so that they can do their

    job professionally and properly, and to have theattitude and awareness to carry out the

    appropriate high-GMP.

  • 8/3/2019 1. 12 Aspects GMP

    11/59

    Things that need to be considered in thisaspect are:

    Organization, qualification andresponsibility

    The production and quality control within theorganizational structure of the pharmaceuticalcompany led by a different pharmacist responsibilityand authority to both sections is clear. Each part wasgiven full authority and adequate facilities to carry outtheir duties effectively and efficiently. Both parts maynot have other interests outside the factory

    organization, so as to inhibit, limit the liability sectionand cause personal or financial conflict of interestInaddition, a production manager and quality controlshould be a pharmacist skilled,

  • 8/3/2019 1. 12 Aspects GMP

    12/59

    Training

    Training given to all employees, whether relateddirectly to the process of drug production or not.Employees are trained on an activity in

    accordance with their duties and the principlesofGMP. The training given by experts.Particular attention in the training given to those

    who work in the room sterile and for those whowork using materials that have a high risk ofdangerous, toxic, sensitizing.

  • 8/3/2019 1. 12 Aspects GMP

    13/59

    Exercise of the GMP must be done

    continuously and with sufficientfrequency to ensure that employeesunderstand and fully understand the

    requirements ofGMP-related dutiesTraining on GMP implementedaccording to a written program that

    has been approved by the productionmanager and manager oversight.

  • 8/3/2019 1. 12 Aspects GMP

    14/59

    3. BUILDINGS AND FACILITIES Building for the manufacture of the drug has the

    size, design, construction and location sufficient

    to facilitate the implementation of the work,cleaning and maintenance is good. Means ofadequate work is necessary to minimize the riskof error, cross contamination and various other

    errors that can degrade the quality of the drugcan be avoided and controlled.

  • 8/3/2019 1. 12 Aspects GMP

    15/59

    Continue

    Terms of buildings and facilities accordingto GMP are as follows:

    -- Location of buildings designed to preventpollution of the surrounding environment,such as pollution of air, soil and water.

    -- The building is designed and maintainedto protect them from the influence ofweather, flood, seepage through the soil aswell as incoming and animal breeding.

  • 8/3/2019 1. 12 Aspects GMP

    16/59

    Continue

    Necessary considerations in determining thedesign and building layout is as follows:

    1) Compliance with other activities, which maybe done in the same facility or in an adjoiningfacility.

    2) The layout of the space in such a way as toallow production activities can be conductedeffectively and efficiently.

  • 8/3/2019 1. 12 Aspects GMP

    17/59

    Continue

    The division of the class room made for separateroom inside the production buildings, such as

    locker rooms, indoor raw material productionand processing room.

    Availability of storage facilities with specialconditions, for example: temperature, humidityand certain security.

    Making sewerage should be large enough andhave good control boxes.

  • 8/3/2019 1. 12 Aspects GMP

    18/59

    4. EQUIPMENT

    Equipment used in the manufacture of

    drugs has design and proper construction,of adequate size and appropriately placed,so the quality is designed for each drugproduct occurred uniformly from batch tobatch as well as to facilitate cleaning andequipment.

  • 8/3/2019 1. 12 Aspects GMP

    19/59

    Terms ofGMP equipment specified are as follows:D

    esign and

    co

    nstructio

    n1) The equipment used should not react or causedue to the material processed.

    2) Equipment can be cleaned easily both insideand outside as well as the equipment may not causean adverse effect on the product.

    3) All equipment used in processing chemicalsare flammable, or placed in areas where flammablematerials are used, should fitted with explosive-

    proof electrical equipment and properly grounded.4) Equipment used for weighing, measuring,

    testing and record should be calibrated according toa program and the proper procedures.

  • 8/3/2019 1. 12 Aspects GMP

    20/59

    Installation and placement

    1) Installation and equipment placementarranged so that production processes canbe run effectively and efficiently.

    2) Channels of water, steam, compressed airor vacuum should be installed such that iteasily reached during the activity takes

    place.3) Each major equipment should be given aclear identification number.

  • 8/3/2019 1. 12 Aspects GMP

    21/59

    4) All pipe, tanks, steam pipe or pipe casingcooling should be good insulation to prevent anypossible defects and minimize energy loss.

    5) The system-support systems such asheating systems, ventilation, air conditioning,drinking water, water purity, water distillationand other facilities should be validated to ensure

    that the systems always function in accordancewith the objectives.

  • 8/3/2019 1. 12 Aspects GMP

    22/59

    Maintenance

    1) Equipment maintained according toappropriate schedule to keep it functioningproperly and prevent pollution that can changethe identity, quality or purity of the product.

    2) written procedures for maintenance ofequipment made and adhered to.

    3) Notes on the implementation ofmaintenance and use of major equipment are

    recorded in a logbookNote to equipment usedexclusively for one product can be put into batchproduction record of a particular product.

  • 8/3/2019 1. 12 Aspects GMP

    23/59

    5. SANITATION AND HIGIENI

    Sanitation and hygiene levels are high is applied

    to every aspect of drug manufacturing. Thescope of sanitation and hygiene coverspersonnel, premises, equipment and supplies, as

    well as container production, and every thing

    can be a source of productcontaminationSources of pollution should beeliminated through a program of sanitation andhygiene comprehensive and integrated.

  • 8/3/2019 1. 12 Aspects GMP

    24/59

    a. Personnel

    1) All employees undergo health checks before andduring work, and regular eye examinations.

    2) All employees applying good personal hygiene.

    3) Each employee who suffered from a disease that

    can harm the quality of products prohibited fromdealing with the materials to recover.

    4) All employees are to report things that can harmthe product.

    5) Use gloves to avoid direct contact between thehand with the materials and products.

  • 8/3/2019 1. 12 Aspects GMP

    25/59

    6) Employees use protective clothing for its ownsecurity.

    7) Only authorized personnel are allowed to enterrestricted areas of buildings and facilities.

    8) Employees are instructed to wash their handsbefore entering production areas.

    9) Smoking, eating, and drinking are prohibited inproduction areas, laboratories, and other areasthat can harm the product.

    10) The procedure is applied to everyoneindividually.

  • 8/3/2019 1. 12 Aspects GMP

    26/59

    b. Buildings and facilities

    1) The building was designed and constructed appropriatelyto facilitate the implementation of improved sanitation.

    2) Toilet with good ventilation is provided with enough.3) adequate storage for clothes.

    4) The washing is placed outside the sterile area. Wheneverpossible should be equipped with a good system.

    5) Storage, preparation and consumption of food isrestricted in specific areas and meet hygiene standards.

    6) Waste must not be allowed to accumulate and collected in

    appropriate containers.7) Rodenticides, insecticides, fumigation materials, and

    cleaning materials must not contaminate equipment andmaterials.

  • 8/3/2019 1. 12 Aspects GMP

    27/59

    c. Cleaning and Equipment

    1) Equipment is cleaned, maintained and stored in aclean condition and checked for cleanliness beforeuse.

    2) Cleaning is done by vacuum or wet, and wherepossible avoid product contamination.

    3) Cleaning and storage of tools and cleaningmaterials performed in a room separate from theprocessing.

    4) written procedures for cleaning and sanitationmade complied with and implemented.

    5) Note the cleaning, sanitation, sterilization, and theinspection itself is stored.

    Validation of cleaning and sanitation procedures

  • 8/3/2019 1. 12 Aspects GMP

    28/59

    6. PRODUCTION

    Production carried out with establishedprocedures which always can assure drugproducts that meet defined specifications.

  • 8/3/2019 1. 12 Aspects GMP

    29/59

    The starting material

    1. All income, expenses, and the rest of the recordedmaterial, including a description of the inventory.

    2. Each of the starting materials meet specificationsand should be labeled with the name stated in thespecifications.

    3. For each batch of shipment and given a referencenumber that shows a clear identity.

    4. At the time of receipt of goods carried out a visualinspection, and samples taken from the officer,

    were tested against the specifications of thematerial in question.

    5. Post a starting material is quarantined untilapproved and released for use.

  • 8/3/2019 1. 12 Aspects GMP

    30/59

    6. The label placed by officers appointed by the party

    responsible for quality control.7. Beginning inventory is checked once in a while.8. Starting materials that are unstable by the influence

    of temperature, stored in a temperature regulated.

    9. The starting materials which tend to be damaged instorage potential stated age limit.10. Expenditure early material performed by authorized

    personnel.11. Availability of delivery of the remaining areas to

    prevent cross-contamination.12. All starting materials that do not qualify are marked

    cross, stored separately and immediately destroyedor returned to suppliers.

  • 8/3/2019 1. 12 Aspects GMP

    31/59

    Validation Process

    1) All production processes are validated with theappropriate and implemented correctlyaccording to procedures that have beendetermined and the result is stored.

    2) Before a parent applied processing steps shouldbe done to prove the compatibility with theimplementation of the production.

    3) Changes in equipment or material accompanied

    by re-validation action.

    4) Processes and procedures are critically re-evaluated regularly.

  • 8/3/2019 1. 12 Aspects GMP

    32/59

    Contamination Chemical or microbial contamination to a drug

    that can harm health or reduce the therapeuticor affect the quality of a product, can not beaccepted.

    Batch

    and

    lo

    t numbering system1) The numbering system described in detail2) numbering system is intertwined with the

    products made.

    3) The numbering system used to ensure that thenumbers are not repeated and facilitate themarking of a product if anything happens.

    4) Giving the number recorded in a diary.

  • 8/3/2019 1. 12 Aspects GMP

    33/59

    Weighing andDelivery

    1) Method of handling, weighing, calculation anddelivery of materials and products covered by

    written procedures.

    2) All expenditures of materials and products aredocumented.

    3) Materials and products that may be submitted

    only that have been passed by the quality control.4) Prior to the weighing is carried out checks on the

    marking.

    5) capacity, accuracy, and precision scales

    according to the amount of material.

  • 8/3/2019 1. 12 Aspects GMP

    34/59

    ContinuE

    6) At each weighing, measurements weremade documenting the accuracy of the identity andamount of material.

    7) Hygiene and weighing the delivery is maintained.

    8) Penimbangan dan penyerahan menggunakanperalatan yang cocok dan bersih. Weighing and

    delivery using appropriate equipment and clean.

    9) Raw materials delivered product be re-examined tominimize the risk of misuse and errors of rawmaterials to be produced

  • 8/3/2019 1. 12 Aspects GMP

    35/59

    Return

    All materials early, packaging materials,intermediate products and bulk products

    are returned to the warehouse is a productthat meets predetermined specificationsand documented properly anddirekonsilasi.

  • 8/3/2019 1. 12 Aspects GMP

    36/59

    Processing

    1) All materials used are checked first.

    2) The condition is monitored and controlledprocessing area.

    3) The equipment used is checked first.

    4) All processing activities follow writtenprocedures that have been determined and

    reported irregularities with the excuses andexplanations.

    5) The container and cover materials and cleanproduct.

  • 8/3/2019 1. 12 Aspects GMP

    37/59

    ContinuE6) All containers and equipment containing

    materials and products be labeled appropriately.

    7) All products are labeled right and quarantined

    until released by the quality control.

    8) The whole monitoring process should berecorded and investigated.

    9) The results are recorded and matched the realview of the theoretical results.

    10) In all stages of processing, consider theproblem of cross contamination.

  • 8/3/2019 1. 12 Aspects GMP

    38/59

    Materials anddried products

    1) Material and dry products, handling a problem ofdust, and therefore need to be mounted vacuumsystem to prevent the spread of dust.

    2) The mixing and granulation. Mixing machine,sieving and stirrer equipped with a dust controlsystem. And operational parameters are listed in

    the Master Production Documents..

  • 8/3/2019 1. 12 Aspects GMP

    39/59

    ContinuE

    3) Printing tablets. Machines equipped withadequate facilities, conducted a physical control,procedural and tagging.

    4) Coating. Using a spray device that worksautomatically and has validated the power spray.

    5) Charging hard capsules, empty capsules as astarting material, kept in good condition.

    6) Marking coated tablets and capsules should beclear and understandable.

  • 8/3/2019 1. 12 Aspects GMP

    40/59

    7. QUALITY CONTROL

    Quality control is an essential part ofGMP that anyof the drugs are designed to meet the quality

    requirements set. Main tasks include thepreparation of quality control procedures,preparation, instruction, sampling plan, passed orrejected materials and products, examined the

    record before the product is distributed, settingexpiration date, re-evaluate the test, approve theappointment of suppliers, evaluate the complaint.

  • 8/3/2019 1. 12 Aspects GMP

    41/59

    In the quality control of the things that need to beconsidered include:

    How to berlaboratorium good quality control Laboratory testing includes the buildings and

    tools supporting full and adequate, trained andresponsible personnel, equipment instrumentsand procedures that are suitable for periodiccalibration, reagents and culture media inaccordance with the monograph in question,specifications and testing procedures are

    validated with the facilities used , recordsconcerning all aspects of testing required andthe remaining stored samples used insubsequent testing.

  • 8/3/2019 1. 12 Aspects GMP

    42/59

    Monitoring of the starting materials,

    intermediate products, bulk product, andfinished drug

    That must be considered in this regard is thespecification, the way sampling, testing of raw

    materials, packaging, intermediates, bulk andfinished drug products, sterilization tests forsterile products, test pirogenitas and periodicenvironmental monitoring of chemical and

    microbiological quality of water and productionenvironment.

  • 8/3/2019 1. 12 Aspects GMP

    43/59

    Documentation

    Important documentation relating to qualitycontrol, which contains: specification, samplingprocedures, recording procedures and testing(including analysis worksheet and / or

    laboratory notebooks), reports and / orcertificate of analysis / environmentalmonitoring data (if necessary), record validationmethods of analysis (when necessary),

    procedures and instrument calibration recordsand maintenance equipment.

  • 8/3/2019 1. 12 Aspects GMP

    44/59

    Sampling

    Sampling is an important activity of the qualityassurance system. Personnel who take samplesmust obtain initial training and periodic training.

    Sampling was carried out on starting materialsand packaging materials. The number of samplestaken should be determined statistically andspecified in the pattern of sampling. Samplingactivities conducted in such a way as to preventcontamination or other effects that affect quality.

  • 8/3/2019 1. 12 Aspects GMP

    45/59

    Testing requirements Tests carried out on starting materials,

    packaging materials, intermediate products,bulk products and finished products inaccordance with established specifications.

    Control over the environment should be made asfollows: monitoring of water for the process bedone periodically, microbiological monitoringperformed in a production environment on aregular basis, monitoring the environment

    around the production area to detect otherproducts that may contaminate the productsmade at regular intervals, and control of aircontaminant.

  • 8/3/2019 1. 12 Aspects GMP

    46/59

    All process controls carried out according tomethods approved by the Quality Supervision andthe results recorded. After a storage time limit forstarting materials, intermediate products, bulk

    products and finished products is carried outretesting.

  • 8/3/2019 1. 12 Aspects GMP

    47/59

    Conducted additional testing of materials infinished products of reprocessing. Qualitycontrol procedures to participate in making theprocessing stem and stem packing procedures.

    Stability studies designed to determine thestability of the product, and the program isadhered to and including the number, storageconditions, and testing methods. Stability

    studies conducted on new products, newpackaging, changes to the formula and the batchreleased.

  • 8/3/2019 1. 12 Aspects GMP

    48/59

    8. SELF INSPECTION AND AUDIT

    QUALITY

    The goal is self-inspections to assess whether allaspects of production and quality control always

    meet GMP.The things to note are: Things that are inspected include employees,buildings, storage, starting materials andfinished drug medication, equipment,

    production, quality control, documentation,maintenance of buildings and equipment.

  • 8/3/2019 1. 12 Aspects GMP

    49/59

    Audit quality is useful as a complement of self-

    inspections, including examination andassessment of all or part of the qualitymanagement system with specific objectives toimprove the quality generally conducted by

    outside or independent specialists or specialteams.

  • 8/3/2019 1. 12 Aspects GMP

    50/59

    9.Against Handling Products, Product

    Recalls and Product Returns

    Withdrawal of the drug to be drawing back one

    or several batches. This is done when there areproducts that cause side effects or other medicalproblems related to physical, allergic reactions,toxic effects. Handling complaints and reports

    should be recorded and immediately addressedlater conducted research and evaluation.

  • 8/3/2019 1. 12 Aspects GMP

    51/59

    Drugs change can be classified as follows: that stillmeets the specifications that can be used, whichcan be reprocessed and that can not be

    reprocessed. The procedure returns include the number of drug

    treatment, quarantine, research, treatment andrecovery, inspection and thorough quality control.

  • 8/3/2019 1. 12 Aspects GMP

    52/59

    10. DOCUMENTATION

    Documentation is part of the drug manufacturing

    and management information system that includesspecification of raw materials, packaging materials,intermediate products, bulk and finished drugproducts, document production, document quality

    control, storage and distribution of documents,documents in the maintenance,

  • 8/3/2019 1. 12 Aspects GMP

    53/59

    11. Preparation and Analysis Based

    on Contract

    Done to avoid misunderstandings that can lead

    or work with a quality product that is notsatisfactory.Written contract between the giverand the recipient of the contract must bemade clearly define the responsibilities andobligations of each party.

  • 8/3/2019 1. 12 Aspects GMP

    54/59

    12.QUALIFICATION AND VALIDATION

    Planning validation

    All validation activities should be planned inadvance and documented as a brief, precise andclear in VMP (Validation Master Plan). VMP atleast include: policy validation; organizational

    structure validation activities; summary of facilities,systems, equipment and processes to be validated;

  • 8/3/2019 1. 12 Aspects GMP

    55/59

    Documentation

    Written validation protocol was made to specifythe qualification and validation to be performed,as well as detailing the critical steps and

    acceptance criteria.Protocols should be reviewedand approved by the Head of QA.

    The report must be made referring to thequalification protocols and / or validation

    protocols that include all the results obtained andthe deviations that occur and the improvementsmade and documented.

  • 8/3/2019 1. 12 Aspects GMP

    56/59

    Qualification

    1) Design Qualification (DQ) Is the first element in validating the facilities,

    systems or new equipment.

    2) Installation Qualification (IQ)

    Made to the facilities, systems and new ormodified equipment. Minimum requirements forIQ were: equipment installation, piping andsupport facilities and instruments according to

    specifications and engineering drawings aredesigned;

  • 8/3/2019 1. 12 Aspects GMP

    57/59

    3) Qualification Oprasional (QO) QO can be performed after RIC. QO minimum include:

    the testing of processes, systems and equipment, andtesting that includes one or several conditions that includeupper and lower limits oprasional.QO formal settlementinclude: calibration, procedures, pengoprasian andcleaning, the selection operator and preventivemaintenance.

    4) Performance Qualification (PQ) PQ carried out after the QO finish, although in some cases

    families are united by knockout.PQ minimum include:Tests using raw materials, substitute materials that meet

    specifications or products conducted simulations based onknowledge about the processes, facilities, systems andequipment,

    5) Qualifying facilities, equipment and systems thathave been installed oprasional

  • 8/3/2019 1. 12 Aspects GMP

    58/59

    Validation process

    Thera are 3 ways to do validation process:

    1) Validation prospektif

    Validation prosecess before product are sell.

    2) Validation konkuren

    Validation process at process production.

    3) Validation retrospektif

    Validation are done at after process before (frondata before). This Validationcan not use ifchange formula, tools dan prosedure

  • 8/3/2019 1. 12 Aspects GMP

    59/59

    THANK YOU